Finesse Pharmaceuticals Private Limited, a active private limited company, was established on 16 January 1985 in Kalol, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85100GJ1985PTC007568. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.50 M and a paid-up capital of ₹4.09 M.
It upholds a compliant status. Employing 10 professional, Its leadership includes Rajshree Pradeep Kothari (Director), Prasann Bharatkumar Shah (Additional Director). Past directors included Harsh Pradeep Kothari, Pradeep Ravichandra Kothari, Rajshree Pradeep Kothari. It holds ₹4.87 Cr open charges and ₹2.15 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 827/6 C P Industrial Estate Santej - Rakanpur, Kalol, Gujarat, 382721.
U85100GJ1985PTC007568
007568
16 January 1985
₹5.50 M
₹4.09 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Finesse Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajshree Pradeep Kothari | Director | 03 Jan 2023 | Current |
| Prasann Bharatkumar Shah | Additional Director | 08 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 01 Apr 2019 | Past |
| Pramod Abcsdd | Director | 18 Jun 2024 | Past |
| Pramod Abcsdd | Managing Director | 10 Mar 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Finesse Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.15% increase. The company also saw a substantial improvement in profitability, with a 20.89% increase in profit. The company's net worth Soared by an impressive increase of 56.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Finesse Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹48,657,000.00
₹2,152,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Jul 2025 | Sidbi | ₹2.99 Cr | Open |
| 21 Apr 2007 | Canara Bank | ₹0.41 M | Open |
| 11 Feb 2006 | Canara Bank | ₹1.83 Cr | Open |
| 03 Oct 2011 | Canara Bank | ₹1.15 M | Satisfied |
| 16 Feb 1998 | Progressive Merantile Co-Op Bank Ltd | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Finesse Pharmaceuticals has a workforce of 10 employees as of Mar 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Finesse Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finesse Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Sidbi amounted to Rs. 29.90 M with Charge ID 101116338 was registered on 01 Jul 2025. was completed.
Prasann Bharatkumar Shah was appointed as a Additional Director was appointed as a Additional Director on 08 Nov 2024 & has been associated with this company since 1 year 21 days . was recorded as a recent event.
The activity Finesse Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Finesse Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
A charge with Canara Bank of Rs. 18.35 M registered on 11 Feb 2006 with Charge ID 80029051 was modified on 11 Jan 2023. was recorded as a recent event.
Progress on Rajshree Pradeep Kothari was appointed as a Director was appointed as a Director on 03 Jan 2023 & has been associated with this company since 2 years 10 months . was documented.
The CIN of Finesse Pharmaceuticals Private Limited is U85100GJ1985PTC007568.
Finesse Pharmaceuticals Private Limited is headquartered at 827/6 C P Industrial Estate Santej - Rakanpur, Kalol, Gujarat, 382721.
Finesse Pharmaceuticals Private Limited was incorporated on 16 January 1985.
The current directors of Finesse Pharmaceuticals Private Limited are
The primary industry of Finesse Pharmaceuticals Private Limited is Manufacturing.
Finesse Pharmaceuticals Private Limited is unlisted.
The authorized capital of Finesse Pharmaceuticals Private Limited is ₹5.50 M, and the paid-up capital is ₹4.09 M.
The compliance status of Finesse Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX